Trends in Prepregnancy Obesity and Association With Adverse Pregnancy Outcomes in the United States, 2013 to 2018
Michael C Wang1, Priya M Freaney1,2, Amanda M Perak1,3
1Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.
Insights
Prevalence of prepregnancy obesity and related adverse pregnancy outcomes (APOs) increased from 2013-2018, particularly pregnancy-associated hypertension. These trends varied by race/ethnicity, highlighting disparities in maternal cardiometabolic health.
Area of Science:
- Reproductive Health
- Maternal-Fetal Medicine
- Public Health Epidemiology
Background:
- Rising obesity rates parallel increasing adverse pregnancy outcomes (APOs).
- Understanding contemporary trends in prepregnancy obesity and APOs is crucial for targeted prevention.
- Optimizing maternal and offspring cardiometabolic health requires data on obesity-related pregnancy complications.
Purpose of the Study:
- To quantify trends in prepregnancy obesity prevalence from 2013-2018.
- To assess associations between prepregnancy obesity and adverse pregnancy outcomes (APOs).
- To examine racial/ethnic disparities in obesity prevalence and APOs.
Main Methods:
- Serial, cross-sectional study using National Center for Health Statistics birth certificate data (2013-2018).
- Analysis included women aged 15-44 with live singleton births, stratified by race/ethnicity.
- Prevalence of obesity and adjusted odds ratios for APOs were calculated using multivariable logistic regression.
Main Results:
- Prepregnancy obesity prevalence increased across all racial/ethnic groups studied (2013-2018).
- Obesity-associated APOs increased, with adjusted odds ratios ranging from 1.27 to 1.94 by 2018.
- Obesity showed the strongest association with pregnancy-associated hypertension; population attributable fractions for APOs also increased.
Conclusions:
- Prepregnancy obesity and its associated APO burden have risen, primarily driven by pregnancy-associated hypertension.
- Significant racial/ethnic variations exist in obesity prevalence and the burden of obesity-related APOs.
- Findings underscore the need for tailored public health interventions to address disparities in maternal cardiometabolic health.
Abstract:
Background The prevalence of obesity in the population has increased in parallel with increasing rates of adverse pregnancy outcomes (APOs). Quantifying contemporary trends in prepregnancy obesity and associations with interrelated APOs (preterm birth, low birth weight, and pregnancy-associated hypertension) together and individually can inform prevention strategies to optimize cardiometabolic health in women and offspring. Methods and Results We performed a serial, cross-sectional study using National Center for Health Statistics birth certificate data including women aged 15 to 44 years with live singleton births between 2013 and 2018, stratified by race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, and non-Hispanic Asian). We quantified the annual prevalence of prepregnancy obesity (body mass index ≥30.0 kg/m2; body mass index ≥27.5 kg/m2 if non-Hispanic Asian). We then estimated adjusted associations using multivariable logistic regression (odds ratios and population attributable fractions) for obesity-related APOs compared with normal body mass index (18.5-24.9 kg/m2; 18.5-22.9 kg/m2 if non-Hispanic Asian). Among 20 139 891 women, the prevalence of prepregnancy obesity increased between 2013 and 2018: non-Hispanic White (21.6%-24.8%), non-Hispanic Black (32.5%-36.2%), Hispanic (26.0%-30.5%), and non-Hispanic Asian (15.3%-18.6%) women (P-trend < 0.001 for all). Adjusted odds ratios (95% CI) for APOs associated with obesity increased between 2013 and 2018, and by 2018, ranged from 1.27 (1.25-1.29) in non-Hispanic Black to 1.94 (1.92-1.96) in non-Hispanic White women. Obesity was most strongly associated with pregnancy-associated hypertension and inconsistently associated with preterm birth and low birth weight. Population attributable fractions of obesity-related APOs increased over the study period: non-Hispanic White (10.6%-14.7%), non-Hispanic Black (3.7%-6.9%), Hispanic (7.0%-10.4%), and non-Hispanic Asian (7.4%-9.7%) women (P-trend < 0.01 for all). Conclusions The prevalence of prepregnancy obesity and burden of obesity-related APOs have increased, driven primarily by pregnancy-associated hypertension, and vary across racial/ethnic subgroups.
Related Concept Videos
Obesity
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Drug Dosing: Obese Patients
Regression Toward the Mean
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution


